Key facts
- RiskAverse’s last known valuation is $5.0M (Apr 2023).
- It has raised $200K; the latest was Later Stage VC in Jan 2025.
- Notable investors include Matter (Consulting Services (B2B)), NZVC, SSC Venture Partners, Biomedical Zone, Diversity Innovation Hub — 8 tracked in total.
- 1 investment vehicle was formed to buy RiskAverse shares in the last 12 months, reporting $130K sold to 6 investors, per SEC Form D filings.
- Status: Privately Held (backing).
- ·The complete investor list — 8 names
- ·Watchlist + deal alerts for RiskAverse
- ·The full record, as it builds
Funding rounds
No funding rounds for RiskAverse are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Secondary demand: investment vehicles
from SEC Form D filingsIn the last 12 months, 1 investment vehicle were formed to buy RiskAverse shares, reporting $130K sold to 6 investors. Most recent filing Dec 2025. Vehicles like these are how secondary buyers pool demand for a name; a rising count is a demand signal.
About RiskAverse
Developer of an artificial intelligence-based healthcare platform designed to manage and optimize patient navigation and member engagement. The company's platform utilizes data analysis to create personalized, multi-channel outreach campaigns and customized interactive workflows, enabling healthcare organizations to improve patient outcomes, increase conversion rates, and boost member satisfaction with minimal coding or engineering.
- Sector
- Healthcare
- HQ
- Westborough, MA, United States
- Founded
- 2018
- Employees
- 3
- Website
- promptwell.com/
- Ownership
- Privately Held (backing)
RiskAverse doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in RiskAverse shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on RiskAverse in its N-PORT filings yet. We sweep new filings monthly.